Inventor · disambiguated record
Peter B. Rahl
Also filed as: RAHL PETER · RAHL PETER B
9 granted patents·8 pending applications·12 citations·filing 2011–2024
82Inventor score
Files withSYROS PHARMACEUTICALS INC7FULCRUM THERAPEUTICS INC5WHITEHEAD INST BIOMEDICAL RES2RAHL PETER B1WHITEHEAD BIOMEDICAL INST1
Top patents by PatentIndex Score
17 records- 0194US10973805B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 13, 2021·5 cites·20 claims
- 0291US11590111B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·10 claims
- 0383US2025195480A1Macrocyclic azolopyridine derivatives as eed and prc2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0481US12109198B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·0 cites·5 claims
- 0579US11124527B2Compounds for the modulation of Myc activitySYROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·2 cites·30 claims
- 0673US9567301B2Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitorsWHITEHEAD INST BIOMEDICAL RES·Filed 2013·Granted Feb 14, 2017·1 cites·10 claims
- 0771US2023144106A1Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0870US10071129B2Method for identifying bromodomain inhibitorsYOUNG RICHARD A·Filed 2012·Granted Sep 11, 2018·1 cites·6 claims
- 0970US9155724B2Combination methods for treatment of diseaseRAHL PETER B·Filed 2011·Granted Oct 13, 2015·1 cites·33 claims
- 1063US11753418B2Compounds for the modulation of Myc activitySYROS PHARMACEUTICALS INC·Filed 2021·Granted Sep 12, 2023·0 cites·30 claims
- 1162US2021188833A1Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1260US2019134141A1Methods of downregulating translocated oncogene expression using bromodomain inhibitorsWHITEHEAD INST BIOMEDICAL RES·Filed 2018·Application pending·0 cites
- 1359US2021221820A1Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1455US10787444B2Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 29, 2020·0 cites·25 claims
- 1549US2022017908A1Compositions and methods for increasing fetal hemoglobin and treating sickle cell diseaseFULCRUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1644US2016032387A1Methods and systems for evaluating genesSYROS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1742US2015167062A1Genome-wide Method of Assessing Interactions Between Chemical Entities And Their Target MoleculesWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter B. Rahl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →